Khanna Ashish K, Garcia Julio O, Saha Amit K, Harris Lynnette, Baruch Martin, Martin R Shayn
Department of Anesthesiology, Section on Critical Care Medicine, School of Medicine, Wake Forest University, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Outcomes Research Consortium, Cleveland, OH, USA.
J Clin Monit Comput. 2024 Feb;38(1):139-146. doi: 10.1007/s10877-023-01059-5. Epub 2023 Jul 17.
Pulse Decomposition Analysis (PDA) uses integration of the systolic area of a distally transmitted aortic pulse as well as arterial stiffness estimates to compute cardiac output. We sought to assess agreement of cardiac output (CO) estimation between continuous pulmonary artery catheter (PAC) guided thermodilution (CO-CCO) and a wireless, wearable noninvasive device, (Vitalstream, Caretaker Medical, Charlottesville, VA), that utilizes the Pulse Decomposition Analysis (CO-PDA) method in postoperative cardiac surgery patients in the intensive care unit.
CO-CCO measurements were compared with post processed CO-PDA measurements in prospectively enrolled adult cardiac surgical intensive care unit patients. Uncalibrated CO-PDA values were compared for accuracy with CO-CCO via a Bland-Altman analysis considering repeated measurements and a concordance analysis with a 10% exclusion zone.
259.7 h of monitoring data from 41 patients matching 15,583 data points were analyzed. Mean CO-CCO was 5.55 L/min, while mean values for the CO-PDA were 5.73 L/min (mean of differences +- SD 0.79 ± 1.11 L/min; limits of agreement - 1.43 to 3.01 L/min), with a percentage error of 37.5%. CO-CCO correlation with CO-PDA was moderate (0.54) and concordance was 0.83.
Compared with the CO-CCO Swan-Ganz, cardiac output measurements obtained using the CO-PDA were not interchangeable when using a 30% threshold. These preliminary results were within the 45% limits for minimally invasive devices, and pending further robust trials, the CO-PDA offers a noninvasive, wireless solution to complement and extend hemodynamic monitoring within and outside the ICU.
脉搏分解分析(PDA)通过对远端传输的主动脉脉搏收缩期面积进行积分以及动脉僵硬度估计来计算心输出量。我们旨在评估在重症监护病房的心脏手术后患者中,连续肺动脉导管(PAC)引导的热稀释法(CO-CCO)与一种无线可穿戴无创设备(Vitalstream,Caretaker Medical,弗吉尼亚州夏洛茨维尔)之间的心输出量(CO)估计值的一致性,该设备采用脉搏分解分析(CO-PDA)方法。
在前瞻性纳入的成人心脏外科重症监护病房患者中,将CO-CCO测量值与经过后处理的CO-PDA测量值进行比较。通过Bland-Altman分析(考虑重复测量)以及10%排除区的一致性分析,将未校准的CO-PDA值与CO-CCO的准确性进行比较。
分析了来自41名患者的259.7小时监测数据,匹配15583个数据点。平均CO-CCO为5.55升/分钟,而CO-PDA的平均值为5.73升/分钟(差异均值±标准差为0.79±1.11升/分钟;一致性界限为-1.43至3.01升/分钟),百分比误差为百分之37.5。CO-CCO与CO-PDA的相关性为中等(0.54),一致性为0.83。
与CO-CCO Swan-Ganz相比,当使用30%阈值时,使用CO-PDA获得的心输出量测量值不可互换。这些初步结果在微创设备45%的限制范围内,在进一步的有力试验之前,CO-PDA提供了一种无创、无线的解决方案,以补充和扩展重症监护病房内外的血流动力学监测。